LPS binding protein (LBP) was discovered about 20 years ago because of its ability to bind to bacterial lipopolysaccharide (LPS). We have shown that in addition to its complex function of transferring LPS to its cellular receptor into the cell or into lipoproteins, LBP also binds to other bacterial compounds and can modulate their ability to stimulate the host's innate immune system. The majority of compounds found to also interact with LBP are amphiphilic molecules such as glycolipids or lipoproteins. Lipoteichoic acid (LTA) of different Gram-positive bacteria is recognized by LBP and both its complexation with CD14 and biological activity towards immune cells is modulated by LBP. LTA-like glycolipids isolated from spirochetes are recognized by LBP and initiate signaling in the presence of LBP. Lipopeptides corresponding to lipoproteins present in spirochetes, Mycobacterium spp. and Gram-negative bacteria as well as Mycoplasma spp. are also recognized by LBP. Together with the growing number of related proteins of the BPI-PLUNC family, LBP apparently as soluble mediator has the important ability to recognize a variety of bacterial pathogens before cellular contact has been established. The different sources of LBP in tissues such as lung and intestine further support its role as an important defense molecule.
Beutler B., Rietschel ETInnate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol2003; 3: 169—176.
2.
Rietschel ET , Brade H., Holst O. et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol1996; 216: 39—81.
3.
Rietschel ET , Cavaillon JMEndotoxin and anti-endotoxin. The contribution of the schools of Koch and Pasteur: life, milestoneexperiments and concepts of Richard Pfeiffer (Berlin) and Alexandre Besredka (Paris). J Endotoxin Res2002; 8: 71—82.
4.
Alexander C. , Rietschel ETBacterial lipopolysaccharides and innate immunity . J Endotoxin Res2001; 7: 167—202.
5.
Tobias PS, Soldau K., Ulevitch RJIsolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med1986; 164: 777—793.
6.
Ulevitch RJ, Mathison JC, Schumann RR, Tobias PSA new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma1990; 30 (12 Suppl): S189—S192.
7.
Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science1990; 249: 1429—1431.
8.
Mathison JC, Tobias PS, Wolfson E., Ulevitch RJPlasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of Gram-negative LPS. J Immunol1992; 149: 200—206.
9.
Lamping N., Hoess A., Yu B. et al. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol1996; 157: 4648—4656.
10.
Schumann RR, Lamping N., Hoess A.Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. J Immunol1997; 159: 5599—5605.
11.
Han J., Mathison JC, Ulevitch RJ, Tobias PSLipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J Biol Chem1994; 269: 8172—8175.
12.
Hailman E., Lichenstein HS, Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med1994; 179: 269—277.
13.
Tobias PS, Soldau K., Gegner JA, Mintz D., Ulevitch RJLipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem1995; 270: 10482—10488.
14.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JCCD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990; 249: 1431—1433.
15.
Schumann RR , Rietschel ET, Loppnow H.The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol (Berl) 1994; 183: 279—297.
16.
Thompson PA , Tobias PS, Viriyakosol S., Kirkland TN, Kitchens RLLipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem2003 ; 278: 28367—28371.
Gegner JA, Ulevitch RJ, Tobias PSLipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem1995; 270: 5320—5325.
19.
Hamann L., Stamme C., Ulmer AJ, Schumann RRInhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein. Biochem Biophys Res Commun2002; 295: 553—560.
20.
Lamping N., Dettmer R., Schröder Nwj et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest1998; 101: 2065—2071.
21.
Zweigner J. , Gramm HJ, Singer OC, Wegscheider K., Schumann RRHigh concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood2001; 98: 3800—3808.
22.
Wurfel MM, Kunitake ST, Lichenstein H., Kane JP, Wright SDLipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med1994; 180: 1025—1035.
Kitchens RL , Thompson PAImpact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res2003; 9: 113—118.
25.
Hamann L., Alexander C., Stamme C., Zahringer U., Schumann RRAcute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms . Infect Immun2005; 73: 193—200.
26.
Gutsmann T. , Müller M., Carroll SF, MacKenzie RC, Wiese A., Seydel U.Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun2001; 69: 6942—6950.
27.
Müller M., Brandenburg K., Dedrick R., Schromm AB, Seydel U.Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J Immunol2005 ; 174: 1091—1096.
28.
Müller M., Scheel O., Lindner B., Gutsmann T., Seydel U.The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J Endotoxin Res2003; 9: 181—186.
29.
Grube BJ, Cochane CG, Ye RD et al. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem1994; 269: 8477—8482.
30.
Schumann RR , Kirschning CJ, Unbehaun A. et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol1996; 16: 3490—3503.
31.
Sablotzki A. , Borgermann J., Baulig W. et al. Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Thorac Cardiovasc Surg2001; 49: 273—278.
32.
Schäfer K., Schumann RR, Stoteknuel S., Schollmeyer P., Dobos GJLipopolysaccharide-binding protein is present in effluents of patients with Gram-negative and Gram-positive CAPD peritonitis. Nephrol Dial Transplant1998; 13: 969—974.
33.
Erwin PJ, Lewis H., Dolan S. et al. Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med2000; 28: 104—109.
34.
Albillos A. , de la Hera A., Gonzalez M. et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement . Hepatology2003; 37: 208—217.
Oude Nijhuis CS, Vellenga E., Daenen SM et al. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med2003; 29: 2157—2161.
37.
Kaden J., Zwerenz P., Lambrecht HG, Dostatni R.Lipopolysaccharide-binding protein as a new and reliable infection marker after kidney transplantation. Transpl Int2002; 15: 163—172.
38.
Pavcnik-Arnol M., Hojker S., Derganc M.Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med2004; 30: 1454—1460.
39.
Behrendt D. , Dembinski J., Heep A., Bartmann P.Lipopolysaccharide binding protein in preterm infants. Arch Dis Child2004; 89: F551—F554.
40.
Henneke P., Osmers I., Bauer K., Lamping N., Versmold HT, Schumann RRImpaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants. J Perinat Med2003; 31: 176—183.
41.
Hallatschek W., Fiedler G., Kirschning CJ et al. Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur J Immunol2004; 34: 1441—1450.
42.
Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WALipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol1999; 163: 2792—2798.
43.
Dentener MA , Vreugdenhil AC, Hoet PH et al. Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol2000; 23: 146—153.
44.
Ren L., Jin L., Leung WKLocal expression of lipopolysaccharide-binding protein in human gingival tissues . J Periodontal Res2004; 39: 242—248.
45.
Li XH, Gong JP, Tu B., Shi YJ, Liu CAIn vivo expression of lipopolysaccharide binding protein and its gene induced by endotoxin. Chin J Traumatol2003; 6: 280—283.
46.
Fan X., Stelter F., Menzel R. et al. Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction. Infect Immun1999; 67: 2964—2968.
47.
Schröder Nwj, Opitz B., Lamping N. et al. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J Immunol2000; 165: 2683—2693.
Morath S., Geyer A., Hartung T.Structure—function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med2001; 193: 393—397.
50.
Schröder Nwj , Morath S., Alexander C. et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem2003; 278: 15587—15594.
51.
Hermann C., Spreitzer I., Schröder Nwj et al. Cytokine induction by purified lipoteichoic acids from various bacterial species — role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFNgamma release. Eur J Immunol2002; 32: 541—551.
52.
Vignal C., Guerardel Y., Kremer L. et al. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14—Toll-like receptor 2-dependent mechanism. J Immunol2003; 171: 2014—2023.
53.
Ma Y., Weis JJBorrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun1993; 61: 3843—3853.
54.
Mühlradt PF , Kiess M., Meyer H., Süssmuth R., Jung G.Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med1997 ; 185: 1951—1958.
55.
Mühlradt PF , Kiess M., Meyer H., Süssmuth R., Jung G.Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun1998; 66: 4804—4810.
56.
Schröder Nwj , Heine H., Alexander C. et al. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol2004; 173: 2683—2691.
57.
Weber JR, Freyer D., Alexander C. et al. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity2003 ; 19: 269—279.
58.
Steiner H.Peptidoglycan recognition proteins: on and off switches for innate immunity . Immunol Rev2004; 198: 83—96.
59.
Jack RS, Fan X., Bernheiden M. et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature1997; 389: 742—745.
60.
Fan MH, Klein RD, Steinstraesser L.et al.An essential role for lipopolysaccharide-binding protein in pulmonary innate immune responses. Shock2002; 18: 248—254.
61.
Yang KK, Dorner BG, Merkel U. et al. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J Immunol2002; 169: 4475—4480.
62.
Fierer J., Swancutt MA, Heumann D., Golenbock D.The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice. J Immunol2002; 168: 6396—6403.
63.
Branger J., Florquin S., Knapp S. et al. LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Int Immunol2004; 16: 1605—1611.
64.
Asai Y., Hashimoto M., Ogawa T.Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions. Eur J Immunol2003; 33: 3196—3204.
Weiss J., Muello K., Victor M., Elsbach P.The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol1984; 132: 3109—3115.
67.
Beamer LJ, Carroll SF, Eisenberg D.The BPI/LBP family of proteins: a structural analysis of conserved regions . Protein Sci1998; 7: 906—914.
68.
Tobias PS, Mathison JC, Ulevitch RJA family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem1988; 263: 13479—13481.
69.
Gray PW, Corcorran AE, Eddy Jr RL, Byers MG, Shows TBThe genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Genomics1993; 15: 188—190.
70.
Kirschning CJ, Au-Young J., Lamping N. et al. Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics1997; 46: 416—425.
71.
Hubacek JA, Buchler C., Aslanidis C., Schmitz G.The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem Biophys Res Commun1997 ; 236: 427—430.
72.
Yu B., Hailman E., Wright SDLipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids . J Clin Invest1997; 99: 315—324.
73.
Elsbach P.The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol1998; 64: 14—18.
74.
Elsbach P., Weiss J.Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol1998; 10: 45—49.
75.
Gioannini TL , Teghanemt A., Zarember KA, Weiss JPRegulation of interactions of endotoxin with host cells. J Endotoxin Res2003; 9: 401—408.
76.
Mulero JJ, Boyle BJ, Bradley S. et al. Three new human members of the lipid transfer/lipopolysaccharide binding protein family (LT/LBP). Immunogenetics2002; 54: 293—300.
77.
Bingle CD, Craven CJMeet the relatives: a family of BPI- and LBPrelated proteins. Trends Immunol2004; 25: 53—55.
78.
Wheeler TT, Haigh BJ, McCracken JY, Wilkins RJ, Morris CA, Grigor MRThe BSP30 salivary proteins from cattle, LUNX/PLUNC and von Ebner's minor salivary gland protein are members of the PSP/LBP superfamily of proteins . Biochim Biophys Acta2002; 1579: 92—100.
79.
Gioannini TL , Teghanemt A., Zhang D.et al.Isolation of an endotoxin—MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci USA2004 ; 101: 4186—4191.
